CDC-Authored Genomics and Precision Health Publications Database

---

Last data update: Jan 13, 2025. (Total: 6490 publications)

All Cancer Diabetes Economic Environmental Equity FHH HLBS ID Implementation ND PGx PI Rare RCH dataset

Filtered By: Select to fine-tune your search Year Journal

Records 1-9 (of 9 Records)

Query Trace: Weldon WC[original query]
Sequence-matching adapter trimmers generate consistent quality and assembly metrics for Illumina sequencing of RNA viruses Nabakooza G , Wagner DD , Momin N , Marine RL , Weldon WC , Oberste MS . BMC Res Notes 2024 17 (1) 308
Fecal shedding of two novel live attenuated oral poliovirus type 2 vaccines candidates by healthy bOPV/IPV-vaccinated infants: two randomized clinical trials. Gast C , Bandyopadhyay AS , Sáez-Llorens X , De Leon T , DeAntonio R , Jimeno J , Aguirre G , McDuffie LM , Coffee E , Mathis DL , Oberste MS , Weldon WC , Konopka-Anstadt JL , Modlin J , Bachtiar NS , Fix A , Konz J , Clemens R , Costa Clemens SA , Rüttimann R . J Infect Dis 2022 226 (5) 852-861
Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine viruses. Wahid R , Mercer L , Macadam A , Carlyle S , Stephens L , Martin J , Chumakov K , Laassri M , Petrovskaya S , Smits SL , Stittelaar KJ , Gast C , Weldon WC , Konopka-Anstadt JL , Oberste MS , Van Damme P , De Coster I , Rüttimann R , Bandyopadhyay A , Konz J . NPJ Vaccines 2021 6 (1) 94
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials. Sáez-Llorens X , Bandyopadhyay AS , Gast C , Leon T , DeAntonio R , Jimeno J , Caballero MI , Aguirre G , Oberste MS , Weldon WC , Konopka-Anstadt JL , Modlin J , Bachtiar NS , Fix A , Konz J , Clemens R , Costa Clemens SA , Rüttimann R . Lancet 2020 397 (10268) 27-38
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials. De Coster I , Leroux-Roels I , Bandyopadhyay AS , Gast C , Withanage K , Steenackers K , De Smedt P , Aerssens A , Leroux-Roels G , Oberste MS , Konopka-Anstadt JL , Weldon WC , Fix A , Konz J , Wahid R , Modlin J , Clemens R , Costa Clemens SA , Bachtiar NS , Van Damme P . Lancet 2020 397 (10268) 39-50
Antifungal triazole posaconazole targets an early stage of the parechovirus A3 life cycle. Rhoden E , Ng TFF , Campagnoli R , Nix WA , Konopka-Anstadt J , Selvarangan R , Briesach L , Oberste MS , Weldon WC . Antimicrob Agents Chemother 2019 64 (3)
Dynamics of Evolution of Poliovirus Neutralizing Antigenic Sites and Other Capsid Functional Domains during a Large and Prolonged Outbreak. Shaw J , Jorba J , Zhao K , Iber J , Chen Q , Adu F , Adeniji A , Bukbuk D , Baba M , Henderson E , Dybdahl-Sissoko N , Macdonald S , Weldon WC , Gumede N , Oberste MS , Kew OM , Burns CC . J Virol 2018 92 (9)
Cold Chain and Virus Free chloroplast-made Booster Vaccine to Confer Immunity Against Different Polio Virus Serotypes. Chan HT , Xiao Y , Weldon WC , Oberste SM , Chumakov K , Daniell H . Plant Biotechnol J 2016 14 (11) 2190-2200
Engineering Enhanced Vaccine Cell Lines to Eradicate Vaccine-Preventable Diseases: The Polio Endgame. van der Sanden SM , Wu W , Dybdahl-Sissoko N , Weldon WC , Brooks P , O'Donnell J , Jones LP , Brown C , Tompkins SM , Oberste MS , Karpilow J , Tripp RA . J Virol 2015 90 (4) 1694-704